Global Ophthalmoplegia Market Growth (Status and Outlook) 2023-2029

Global Ophthalmoplegia Market Growth (Status and Outlook) 2023-2029

Ophthalmoplegia refers to weakness (-paresis) or paralysis (-plegia) of one or more extraocular muscleswhich are responsible for eye movements. It is a physical finding in certain neurologic, ophthalmologic, and endocrine disease. Internal ophthalmoplegia means involvement limited to the pupillary sphincter and ciliary muscle. External ophthalmoplegia refers to involvement of only the extraocular muscles. Complete ophthalmoplegia indicates involvement of both.

LPI (LP Information)' newest research report, the “Ophthalmoplegia Industry Forecast” looks at past sales and reviews total world Ophthalmoplegia sales in 2022, providing a comprehensive analysis by region and market sector of projected Ophthalmoplegia sales for 2023 through 2029. With Ophthalmoplegia sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmoplegia industry.

This Insight Report provides a comprehensive analysis of the global Ophthalmoplegia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ophthalmoplegia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ophthalmoplegia market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmoplegia and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmoplegia.

The global Ophthalmoplegia market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Ophthalmoparesis can involve any or all of the extraocular muscles, which include the superior recti, inferior recti, medial recti, lateral recti, inferior oblique and superior oblique muscles. Treatment and prognosis depend on the underlying condition. For example, in thiamine deficiency, treatment would be the immediate administration of vitamin B1.

This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmoplegia market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
External Ophthalmoplegia
Internuclear Ophthalmoplegia

Segmentation by application
Hospital & Clinics
Ambulatory Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Novartis
Zeiss
Bausch Health
Amritt
Medline Industries
Allergan

Please note: The report will take approximately 2 business days to prepare and deliver.